If Sutherland had not got Dehaan on board a very hostile takeover would possibly succeeded at half the original offer, as that was evident from summer stake builder in 2020 with other institutions probably in the wings looking for a slice of the pie too. Possibly one of the reasons for them leaving and taking no interest in the placing hoping it would't work, hence the drop to 8p post placing. A gamble they lost. At that time too remember, recovery from pandemic was thought to bounce quickly and Saga and Carnival still expected to cruise in that winter.
Still getting very mixed messages on the Corona virus, some suggesting it will be a 'cold' status by spring. Saga rightly still extremely an sensibly cautious. However insurance trading robust and cruise booking at record levels. As PS from stockopedia often opines ' can't understand the crazy volatility is Saga sp now'. As far as the company goes I am confident we are in safe hands with indisputable board track record back at helm. There are other factors not under their control but that goes for any company. GL
Never seen so much confusion about the share consolidation as on this bb. Maybe because the placing price was 15p and the consolidation was 15 to 1. So the new share price for consolidation was 15x 15+ £2.25. The offer price of 33p equates to 15x33= £4.95. Saga presentation today at 11.30 not x 15:)
rugs. Brickell has taken a back seat non exec position to concentrate on funds. Ed Croft seems to spearhead it on his own now . All encouraging stuff guys. I think the market will only react to cast iron results and especially when projects get delayed or behind schedule for whatever reason its not going to allow anything in the price till someone presses the on switch on the cashew processor and has sold a few tons!
have thought that many times about many shares rugs. there never seems to be any correlation.
I notice the enterprise value to market cap is about double and looks like there is some long term debt. Ridiculously low PE . I don't know if Stockopedia is up to date. I get the feeling there is about a year lag sometimes. Certainly won't be renewing my subscription again. Its ok but just don't feel their information is that reliable.
I think its important to differentiate cell ag meat from plant based meat substitutes. I would imagine most vegetarians will still not eat lab meat although many are veggie mainly because they don't like the idea of eating animals because of the way they live or the way they die as well as health issues. There are benefits in lab meat containing lower cholesterol as well as environmental benefits. The crucial factors are price, taste and texture. People who eat meat already are unlikely to be put off by the word 'meat' in the title , indeed its a positive and an important differentiation to veggie substitutes other than by simply saying this product contains meat. It is meat and don't want to in any way disguise that fact. So many people have become vegitarians after visiting farms and seeing what their sausages, beef burgers and lamb shanks look like running around on lush green grass. Take away the gore. the guts and cruelty and meat becomes a much more acceptable source of protein without having to detach oneself from what was a living creature. Its an important step to recognise that meat doesnt have to came from a living animal
although that essentially is where it is grown from. Maybe some aunt particularly fussed about the science but it is important perhaps to acknowledge as much of the truth behind it. Something quite alien to the politics of supermarkets
Terminology is an issue with food production. I agree Lab grown has connotations of Frankenstein, but actually also of health and hygiene. A point I raised with Mr Mellon about shelf life he was very quick to latch on to as a positive in terms of less chance of contamination or food poisoning with lab grown meat compared to farm meat particularly in intensive farming with pesticides, growth hormones, over fertilisation, disease etc. Indeed Lab meat sounds safe to me, but the proof will be in the pudding. If it costs pretty much the same to produce any species of lab grown meat, it could take offal off the table. I remember a butcher trying to convince me ox heart was as good as fillet steak. I stopped going there!
Stenata have been selling down since the placing having held about 11% are now down to less than 3%.
Aberdeen sold half their holding after placing to get their clients the lowest possible price they could like they do. Quite why they have sold again is a mystery, now below 5%. Why can't they be more transparent in these RNS's. Its quite devious the way they make these announcements. We dont know what they are left holding. Clearly between the 2 investment(joke) companies they have had quite a drag on the stock so will be good to see the back of them. I am slightly surprised their have not been any institutional buyers in the last year, might have been one, not sure. Stockopedia small cap reviewer has well over 10% of his portfolio here and as an ex plc accountant has considerable experience. Has written several times about why this is well structured for recovery and targets £12 -15 in 2 or 3 years. Really impressed by the itinerary for some of the river cruises. Might wait till I'm a bit more doddery though before I go on one and if I haven't lost all my money here. But of course its the insurance arm that is the main earner.
Hi IDG. I opted out of FOGB with a small profit. It was beginning to bug me. Firstly I couldn't trade it in my IWEB account which I have now ditched, because they are so useless, secondly I didn't like the share price movements with it dropping to £4 a couple of times for no good reason, thirdly I needed to raise more cash for here and a couple of other stock that had dropped for no sensible reasons. I think LSE just like the name, I think they have quoted a couple of my posts before. Anyway good luck with FOGB. I started off there before buying here. Probably sensible to have a bit of both but I definitely prefer ANIC now. I thought the warrants (28p)might be a bit of a hinderance to the price breaking out again, but tempted to buy more even at this price. Good luck
Bod. Yes Mr Scott has made over 100 stock purchases since January 2020. He is cofounder 2009 and non exec director. I guess he also has something to do with CNIC through Kestrel which I also hold. Cnic has taken a while to take off but suddenly spurted about 35% in last few weeks, be good if that happens here, which I fully expect it too although I suspect todays fall was down to cooling house market. That won't stop people remortgaging etc. House transition is well overdue an overhaul. Made me laugh when somebody commented on lorry drivers being paid more than solicitors. Thats seems quite fair to me being far more productive and a much tougher job.
Oliver Scott is a partner of Kestrel Partners LLP, the Company’s largest shareholder, a business he co-founded in 2009 and which specialises in investing in smaller quoted technology companies. Prior to this, Oliver spent over 15 years advising smaller quoted and unquoted companies, latterly as a director of KBC Peel Hunt Corporate Finance.
Oliver has acted as Kestrel’s representative on various of its public and private investee companies and was previously a non-executive director of IQGeo Group plc and KBC Advanced Technologies plc prior to its takeover by Yokogawa.
Never a truer word :“As the world faces this unprecedented global health crisis, it is clear that no one company can go it alone,” Sanofi CEO Paul Hudson said in a statement. “That is why Sanofi is continuing to complement its expertise and resources with our peers, such as GSK, with the goal to create and supply sufficient quantities of vaccines that will help stop this virus.”
This is why I think Nuvec has potential to be an industry standard. Where one goes they all follow
Robin, thats why I stopped drinking Guinness, that and it doesn't taste as good anymore. Isn't it made now in clone beer town Burton?
I think cell fish is due to market next year according to Mellon although I think Lou mentioned it was still couple of years away. Old news or not , the collaboration with a company like Nomad Foods will help propel the company forward much faster. I wouldn't think there is any need to IPO just now as another fundraise looks imminent. Once they are through regulatory hurdles and have seen the appetite for their fish take off and with the big industry behind it that will greatly enhance the value of the company. As to IPO, who knows better than Mr Cooperhouse with 35 years experience in the food industry. Very exciting times and a very positive outlook for world health
Another contract renewal for Brookcourt. Probably BT, as that s the only one I know of and 'a British Telecoms and Media company' is a bit of a clue. The problem I think with this company is the share will go nowhere without the much advertised acquisition being laid to rest. I don't know any other company that has advertised their intention so loud and for so long without actually doing it. It can only be that that has ****ed the market off as has their track record in dealing with other acquisitions, as did the placing when they gave such a vague reason for as justified as it may have been at that time. Get it sorted and hopefully we can move forward.
its an option to buy shares @28p to raise another 80 million to invest on top of the 60million just raised. By then hopefully many more companies in Anic will have developed to a position to IPO and the sp should be well into 30's or even 40's by then, possibly higher. This is likely to be a very rapidly accelerating sector. Obviously there are relation hurdles but a lot of the sciences is there and main problem now is scaling up which as we have seen in the last few days is attracting the international companies to assist in that development having the marketing experience, cash and production facilities.
Slightwatch. Its about another 3 months as stated in rns before final analysis. I think the news continues to be positive and exciting, but not without a moving situation i.e. developments of vaccines and mutation of virus etc. The encouraging parts are lower doses and possibly higher or more efficient immunisation and of course transportation and storage simplified without a need for refrigeration at challenging temperatures of -70%. The markets art going to budge much until evidence of monetisation. A lot depends on the kind of deal sought and how many different vaccines can benefit from Nuvec. License or outright sale. Would have thought this could be an industry wide solution.
Re Bluenalu: Agronomics currently holds 192,005 shares of BlueNalu, comprised of 43,357 Seed Preferred Shares and 148,648 Series A Preferred Shares, with a book value, excluding the CPN investment, of £2,744,613. Agronomics' CPN, and all other CPNs raised in this round, will convert at a Qualified Financing, being an equity fundraise of US$ 50 million or greater. Assuming a Qualified Financing occurs at a price equal to the agreed valuation cap of the CPN, Agronomics will have an approximate equity interest of 5.85% of issued shares following conversion and would value Agronomics' position at approximately £13.4 million. However, for the time-being, the CPN doesn't qualify as a valuation event for Agronomics to revalue its investment in its own books.
Not sure whether todays RNS is a reminder or telling us they now qualify. I see also in the RNS on January 19th, Jim Mellon was appointed to the board as 'an observer' with 6 other investors.
I did say keep it coming Q, can you slow down a bit now , don't think my blood pressure can take it!
This is an extraordinary run of news after a relatively quiet period for ANIC. Hope we get some more investments in the bag soon with all that cash lolling about.